Pharmaceuticals

AstraZeneca acquires EsoBiotec in $1 bn deal
18 Mar 2025
British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

Sun Pharma to acquire oncology therapy company Checkpoint in US
11 Mar 2025
Sun Pharmaceutical Industries Ltd has entered into an agreement to acquire US-based immunotherapy and targeted oncology company, Checkpoint Therapeutics Inc

CSIR develops antibiotic for drug-resistant bacteria, indigenous formula for Paracetamol
08 Jan 2025
Council of Scientific and Industrial Research (CSIR) has reported important breakthroughs, which include development of an anti-biotic to fight drug-resistant bacteria

Govt sets goal higher for India’s nutraceutical industry
08 Nov 2024
India is set to play a major role in the global nutraceutical industry, with its wealth of traditional knowledge, its Ayurveda system and policy support, as per government projections.

Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs
30 Oct 2024
The maximum retail prices (MRP) of three main drugs used in the treatment of cancer, viz, Trastuzumab, Osimertinib and Durvalumab

Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious
27 Oct 2024
A routine inspection by the Central Drug Regulatory Authority of retail medical shops in select locations of Odisha
.webp)
Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences
24 Oct 2024
US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion

NPPA hikes ceiling prices of 8 essential drugs by 50%
16 Oct 2024
National Pharmaceutical Pricing Authority (NPPA) has approved a 50 per cent increase in the ceiling prices of 11 scheduled formulations of eight drugs

Novartis India refutes media reports of negotiations with Alkem Labs
27 Sep 2024
Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.

Mankind Pharma to buy Bharat Serums and Vaccines in a Rs13,630-cr deal
27 Jul 2024
Mankind Pharma is acquiring Bharat Serums and Vaccines (BVS) from private equity firm Advent International in a deal valued at Rs13,630 crore.